Colorectal carcinoma (CRC) · None

Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.

Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.

Source YAML: complete record

Track	aggressive
Linked regimen	`None`

ID	`IND-LYNCH-CARRIER-INTENSIFIED`
Type	Indication
Status	reviewed 2026-05-18 \| pending_clinical_signoff
Diseases	`DIS-CRC`
Sources	`SRC-ASCO-ACMG-LYNCH-2014` `SRC-ESMO-CRC-2024` `SRC-NCCN-GENETIC-FAMILIAL-CRC-2025`

Notes

STUB — v0.2-B confirmed-carrier intensified track (Lynch). Sibling — IND-LYNCH-CARRIER-SURVEILLANCE (standard plan_track). §15.2 C4 ≥2-tracks invariant compliance.

Used By

Indication

IND-CASCADE-LYNCH-FDR-POSITIVE-TESTING - IND-CASCADE-LYNCH-FDR-POSITIVE-TESTING
IND-LYNCH-CARRIER-SURVEILLANCE - IND-LYNCH-CARRIER-SURVEILLANCE

Red flag

RF-LYNCH-CONFIRMED-CARRIER - Confirmed germline pathogenic / likely-pathogenic variant in a Lynch syndrome (MMR / EPCA...